NetworkNewsBreaks – Cannabis Global Inc. (CBGL)
Post# of 112
Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies, has added tetrahydrocannabinol (“THC”) to its Project Varin research program. CBGL is conducting the program in partnership with Natural Plant Extract of California Inc (“NPE”), a licensed and regulated cannabis products manufacturer. The objective of the program is to demonstrate the cost advantages of using the company’s proprietary and provisional patent-pending nanoparticle and nanofiber technologies to change the cost model as it related to adding THC to various products. Cannabis Global filed six provisional patent applications last year, including one which outlined the methods and technologies to create new forms of polymeric cannabinoid nanoparticles. CBGl is also including other cannabinoids, such as tetrahydrocannabivarin (“THC-V”) and cannabinol (“CBN”) in its research. The company intends to add THC to the program with the end goal of creating new particles and fibers that product formulators and manufacturers can use. “Our goal with THC and Project Varin is simple: delivering to the cannabis industry a better form of THC that is substantially more effective, less expensive, and free of the potentially dangerous chemicals used in currently available formulations,” Cannabis Global CEO Arman Tabatabaei stated in the press release. “Over the past few months, our research program has made substantial progress toward these goals with strong successes in CBD, Tetrahydrocannabivarin (‘THC-V’), and Cannabinol (‘CBN’). By applying what we have learned thus far to THC, we hope to formulate an entirely new class of THC product for the cannabis industry that will be included under our nanotechnology provisional patent filing and future patent applications.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer